Japanese electronics manufacturer Casio Computer will release its skin cancer detection devices in foreign markets, anticipating demand in countries with higher rates of the condition.
Publications
The Food and Drug Administration (FDA) grants IO Biotech breakthrough therapy designation for IO102 and IO103 in combination with anti-PD-1 in unresectable/ metastatic melanoma
IO Biotech today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for a combination of the potential therapy IO102 and IO103 with anti-PD-1 mAb for patients with unresectable/ metastatic melanoma.
Statins may reduce disease recurrence in patients with ulcerated primary melanoma
This study was undertaken to determine if long?term statin use commenced before the diagnosis of a primary melanoma is correlated with decreased risk of melanoma recurrence.
Upregulated histone deacetylase 6 associates with malignant progression of melanoma and predicts the prognosis of patients
Whether histone deacetylase 6 (HDAC6) has predictive value for the prognosis of patients suffering from cutaneous melanoma, was investigated herein.